Jung Hye Kwon

5.2k total citations · 1 hit paper
147 papers, 3.4k citations indexed

About

Jung Hye Kwon is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jung Hye Kwon has authored 147 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Oncology, 61 papers in Public Health, Environmental and Occupational Health and 28 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jung Hye Kwon's work include Palliative Care and End-of-Life Issues (56 papers), Cancer survivorship and care (29 papers) and Childhood Cancer Survivors' Quality of Life (20 papers). Jung Hye Kwon is often cited by papers focused on Palliative Care and End-of-Life Issues (56 papers), Cancer survivorship and care (29 papers) and Childhood Cancer Survivors' Quality of Life (20 papers). Jung Hye Kwon collaborates with scholars based in South Korea, United States and Ethiopia. Jung Hye Kwon's co-authors include Éduardo Bruera, David Hui, Jung Hun Kang, Sun‐Hyun Kim, Gary B. Chisholm, Maxine de la Cruz, Rony Dev, Ronald D. Hutchins, Kimberson Tanco and Sriram Yennurajalingam and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jung Hye Kwon

139 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Overcoming Barriers in Cancer Pain Management

2014 274 citations Jung Hye Kwon Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jung Hye Kwon South Korea	29	1.6k	1.2k	943	589	454	147	3.4k
Jamie H. Von Roenn United States	28	1.9k 1.2×	2.3k 1.9×	1.3k 1.4×	235 0.4×	390 0.9×	76	4.4k
J. Lynn Palmer United States	30	657 0.4×	816 0.7×	496 0.5×	204 0.3×	558 1.2×	66	3.2k
Hamutal Friedlander-Klar United States	10	729 0.5×	1.4k 1.2×	744 0.8×	343 0.6×	656 1.4×	12	2.6k
Qiuling Shi China	34	540 0.3×	1.8k 1.5×	565 0.6×	176 0.3×	628 1.4×	248	4.1k
Guibo Xing United States	27	835 0.5×	598 0.5×	534 0.6×	182 0.3×	245 0.5×	73	2.3k
Anders Bonde Jensen Denmark	39	1.7k 1.0×	2.1k 1.7×	725 0.8×	81 0.1×	587 1.3×	150	5.4k
Gerhild Becker Germany	26	811 0.5×	393 0.3×	336 0.4×	142 0.2×	560 1.2×	107	2.4k
Carlos Eduardo Paiva Brazil	27	1.2k 0.7×	974 0.8×	524 0.6×	78 0.1×	191 0.4×	161	2.6k
Jennifer Philip Australia	31	2.0k 1.3×	828 0.7×	978 1.0×	122 0.2×	190 0.4×	224	3.3k
Janet L. Abrahm United States	27	612 0.4×	436 0.4×	253 0.3×	104 0.2×	533 1.2×	92	2.1k

Countries citing papers authored by Jung Hye Kwon

Since Specialization

Citations

This map shows the geographic impact of Jung Hye Kwon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung Hye Kwon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung Hye Kwon more than expected).

Fields of papers citing papers by Jung Hye Kwon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jung Hye Kwon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung Hye Kwon. The network helps show where Jung Hye Kwon may publish in the future.

Co-authorship network of co-authors of Jung Hye Kwon

This figure shows the co-authorship network connecting the top 25 collaborators of Jung Hye Kwon. A scholar is included among the top collaborators of Jung Hye Kwon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jung Hye Kwon. Jung Hye Kwon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jeong, Jae Jun, Jung Hye Kwon, Jiseon Lee, Jochen Weiß, & Mi‐Jung Choi. (2025). Enhancing the stability of xanthan/locust bean gum–based double emulsions using canola and medium-chain triglyceride oils: Examination of physicochemical and thermal properties. Food Chemistry. 489. 145078–145078. 4 indexed citations

Kim, Hong Jun, Eun Hee Jung, Jung Hye Kwon, et al.. (2024). Psychometric Validation of Sheffield Profile for Assessment and Referral to Care (SPARC) in Korean Cancer Patients. Cancer Research and Treatment. 57(3). 891–898.

Shin, Sung Joon, et al.. (2024). Navigating shared decision-making after the Life-Sustaining Treatment Decision Act: a qualitative study of in-depth interviews with terminal cancer patients, families, and healthcare professionals. Supportive Care in Cancer. 32(12). 796–796. 1 indexed citations

Lim, Yoojoo, Chan‐Young Ock, Gahee Park, et al.. (2023). Artificial intelligence‐powered spatial analysis of tumor‐infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma. Head & Neck. 45(12). 3086–3095. 5 indexed citations

Won, Young‐Woong, Jin‐Hyoung Kang, Jung Hye Kwon, et al.. (2023). A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapy. Cancer Research and Treatment. 55(4). 1096–1103. 1 indexed citations

Kwon, Jung Hye, Seung‐Hoon Beom, Sang Joon Shin, et al.. (2023). Outcomes of an Acute Palliative Care Unit at a Comprehensive Cancer Center in Korea. SHILAP Revista de lepidopterología. 4(1). 9–16. 1 indexed citations

Kang, Eun Joo, Myung‐Ju Ahn, Chan-Young Ock, et al.. (2021). Randomized Phase II Study of Axitinib versus Observation in Patients with Recurred or Metastatic Adenoid Cystic Carcinoma. Clinical Cancer Research. 27(19). 5272–5279. 39 indexed citations

Kim, Hwa Jung, Jung Hye Kwon, Sun Kyung Baek, et al.. (2021). The Situation of Life-Sustaining Treatment One Year after Enforcement of the Act on Decisions on Life-Sustaining Treatment for Patients at the End-of-Life in Korea: Data of National Agency for Management of Life-Sustaining Treatment. Cancer Research and Treatment. 53(4). 897–907. 16 indexed citations

Park, Hye Yoon, Young Ae Kim, Jin-Ah Sim, et al.. (2018). Attitudes of the General Public, Cancer Patients, Family Caregivers, and Physicians Toward Advance Care Planning: A Nationwide Survey Before the Enforcement of the Life-Sustaining Treatment Decision-Making Act. Journal of Pain and Symptom Management. 57(4). 774–782. 26 indexed citations

10.

Yun, Young Ho, Kyoung‐Nam Kim, Jin-Ah Sim, et al.. (2018). Comparison of attitudes towards five end-of-life care interventions (active pain control, withdrawal of futile life-sustaining treatment, passive euthanasia, active euthanasia and physician-assisted suicide): a multicentred cross-sectional survey of Korean patients with cancer, their family caregivers, physicians and the general Korean population. BMJ Open. 8(9). e020519–e020519. 24 indexed citations

11.

Kwon, Jung Hye, Jin Hyoung Kang, Ho Jung An, et al.. (2018). Ramosetron versus palonosetron in combination with aprepitant and dexamethasone for the control of highly emetogenic chemotherapy-induced nausea and vomiting. Annals of Oncology. 29. viii610–viii610. 1 indexed citations

12.

Choi, Jung Hye, Tae Min Kim, Hyo Jung Kim, et al.. (2017). Multicenter Retrospective Analysis of Clinical Characteristics, Treatment Patterns, and Outcomes in Very Elderly Patients with Diffuse Large B-Cell Lymphoma: The Korean Cancer Study Group LY16-01. Cancer Research and Treatment. 50(2). 590–598. 7 indexed citations

13.

Kwon, Jung Hye, David Hui, & Éduardo Bruera. (2015). A Pilot Study To Define Chemical Coping in Cancer Patients Using the Delphi Method. Journal of Palliative Medicine. 18(8). 703–706. 30 indexed citations

14.

Koo, Hoon Jung, et al.. (2015). The Double Meaning of Online Social Space: Three-Way Interactions Among Social Anxiety, Online Social Behavior, and Offline Social Behavior. Cyberpsychology Behavior and Social Networking. 18(9). 514–520. 12 indexed citations

15.

Kwon, Jung Hye. (2014). Overcoming Barriers in Cancer Pain Management. Journal of Clinical Oncology. 32(16). 1727–1733. 274 indexed citations breakdown →

16.

Bi, Yan, Jiachu Li, Baoan Ji, et al.. (2014). Sphingosine-1-Phosphate Mediates a Reciprocal Signaling Pathway between Stellate Cells and Cancer Cells that Promotes Pancreatic Cancer Growth. American Journal Of Pathology. 184(10). 2791–2802. 28 indexed citations

17.

Hui, David, Zohra Nooruddin, Neha Didwaniya, et al.. (2013). Concepts and Definitions for “Actively Dying,” “End of Life,” “Terminally Ill,” “Terminal Care,” and “Transition of Care”: A Systematic Review. Journal of Pain and Symptom Management. 47(1). 77–89. 251 indexed citations

18.

Kwon, Jung Hye, Jung Han Kim, Jung-Ae Lee, et al.. (2010). Phase II study with fractionated schedule of docetaxel and cisplatin in patients with advanced non-small cell lung cancer. Cancer Chemotherapy and Pharmacology. 66(5). 889–897. 5 indexed citations

19.

Kim, Seok Jin, Hyo Jin Lee, Hawk Kim, et al.. (2007). Varicella Zoster Virus Reactivation with the Use of Bortezomib in Relapsed or Refractory Multiple Myeloma Patients.. Blood. 110(11). 4843–4843.

20.

Kim, Hyun Jung, Hyun Joo Jang, Hyeon Yoon, et al.. (2005). Clinical Features of Hospitalized Adults with Infectious Mononucleosis. The Korean Journal of Hematology. 40(1). 1–1.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact